Get started
Author

Elizabeth J. Ilett

Observed names: E Ilett, E J Ilett, E. Ilett, E.J. Ilett, EJ Ilett, Elizabeth Ilett, Elizabeth J Ilett, Ilett, E, Ilett, E, L J Ilett, Liz Ilett
Observed institutions: University of Leeds, Mayo Clinic, Institute of Cancer Research, Leiden University Medical Center, Cancer Research UK, St James's University Hospital, University of Surrey, Oncolytics Biotech (Canada)
ORCID: 0000-0002-9875-0322
Observed ORCID: 0000-0002-9875-0322
OpenAlex ID: A5064745768
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
2018 · Adel Samson, Karen J. Scott, et al. · Science Translational Medicine · 374
Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8 + T cell trafficking
2018 · David Taggart, Tereza Andreou, et al. · Proceedings of the National Academy of Sciences · 212
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
2009 · Robin J. Prestwich, Elizabeth J. Ilett, et al. · Clinical Cancer Research · 184
PDF
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
2008 · Robin J. Prestwich, Fiona Errington, et al. · Clinical Cancer Research · 184
PDF
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
2015 · Karishma Rajani, Christopher Parrish, et al. · Molecular Therapy · 183
PDF
Past, Present and Future of Oncolytic Reovirus
2020 · Louise Müller, Robert Berkeley, et al. · Cancers · 129
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
2009 · E J Ilett, R J Prestwich, et al. · Gene Therapy · 123
The Immune System — is it Relevant to Cancer Development, Progression and Treatment?
2007 · R.J. Prestwich, F. Errington, et al. · Clinical Oncology · 112
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
2012 · Jose Pulido, Timothy Kottke, et al. · Nature Biotechnology · 105
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma
2008 · F Errington, C L White, et al. · Gene Therapy · 105
PDF
Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization
2011 · Elizabeth J. Ilett, Montserrat Bárcena, et al. · Clinical Cancer Research · 97
PDF
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
2011 · Timothy Kottke, Fiona Errington, et al. · Nature Medicine · 95
Reciprocal Human Dendritic Cell–Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus
2009 · Robin J Prestwich, Fiona Errington, et al. · The Journal of Immunology · 80
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
2016 · E Ilett, T Kottke, et al. · Gene Therapy · 77
PDF
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming
2011 · Lynette Steele, Fiona Errington, et al. · Molecular Cancer · 77
PDF
Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy
2018 · Robert A. Berkeley, Lynette P. Steele, et al. · Cancer Immunology Research · 75
PDF
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus
2014 · Elizabeth Ilett, Timothy Kottke, et al. · Molecular Therapy · 73
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
2015 · Julia V. Cockle, Karishma Rajani, et al. · Neuro-Oncology · 65
Lymphokine‐activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
2013 · V.A. Jennings, E.J. Ilett, et al. · International Journal of Cancer · 58
PDF
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
2015 · C Parrish, G B Scott, et al. · Leukemia · 51
PDF
The evolving role of dendritic cells in cancer therapy
2010 · EJ Ilett, RJD Prestwich, et al. · Expert Opinion on Biological Therapy · 40
JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
2009 · Alison E Merrick, Elizabeth J Ilett, et al. · PubMed · 40
Cell migration in paediatric glioma; characterisation and potential therapeutic targeting
2015 · J V Cockle, S Picton, et al. · British Journal of Cancer · 37
PDF
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
2012 · Diana M Rommelfanger, Marta C Grau, et al. · Molecular Therapy · 36
Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
2017 · Julia V. Cockle, Anke Brüning-Richardson, et al. · Molecular Therapy — Oncolytics · 34
PDF
Works count: 89
Citation count: 2,831
H-index: 27
I10-index: 32
Year
Topic
Type